ArticleCancer biology & therapy2023

A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer.

Sarah E Paraghamian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.